Product Program year 2025 Source: CMS Open Payments

ORIGIO Sequential Fert

Device Devices

PDI 00888937804157

Open in the dashboard

General payments

$443,743

217 payments

Research payments

$0

0 payments

Through program year 2025, $443,743 in general payments and $0 in research payments were reported against ORIGIO Sequential Fert (Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $441,151 179
2024 General $2,093 27
2023 General $49 2
2022 General $451 9

Breakdown

Who paid General payments · program years 2022–2025
  1. CooperSurgical, Inc. $443,743 217 payments
Top recipients General payments · program year 2025
  1. Brigham And Womens Hospital Teaching hospital · MA $376,676 85% · 2 payments
  2. Theresa Huszar Milford, CT $54,748 12% · 4 payments
  3. James Lin Reproductive Endocrinology · Irvine, CA $548 <1% · 5 payments
  4. Michael Scheiber Reproductive Endocrinology · Cincinnati, OH $478 <1% · 4 payments
  5. Daniel Williams Reproductive Endocrinology · Sugar Land, TX $449 <1% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Reproductive Endocrinology Obstetrics & Gynecology $7,648 81% · 104 practitioners
  2. Obstetrics & Gynecology $1,421 15% · 23 practitioners
  3. Surgery $149 2% · 1 practitioner
  4. Nurse Practitioner, Women's Health Nurse Practitioner $119 1% · 5 practitioners
  5. General Practice $49 <1% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Massachusetts $376,676 85% · 1 recipient
  2. Connecticut $54,863 12% · 2 recipients
  3. Ohio $2,236 <1% · 18 recipients
  4. California $1,740 <1% · 26 recipients
  5. Texas $1,298 <1% · 6 recipients

The top 5 of 30 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

217 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record